Holsboer Florian
Founder and Member of the Scientific Advisory Boar
research
Affectis Pharmaceuticals
Germany
Biography
Florian Holsboer M.D., Ph.D, is a Founder of Affectis Pharmaceuticals Ag and served as Chairman and Member of its Supervisory Board until June 20, 2007. Prof. Holsboer serves as Director of the Max-Planck Institute of Psychiatry in Munich, one of the world's foremost research centres in the field of psychiatry, neurology, and neuroradiology. He serves as a Member of the Scientific Advisory Board of Affectis Pharmaceuticals Ag. He serves as a Member of Scientific Advisory Board of Corcept Therapeutics Inc. He is among the firsts to show that regulation of stress hormones such as the corticotropin-releasing factor (CRF) are involved in the pathogenesis of affective disorders through the hypothalamic-pituitary-adrenal (HPA) system. Prof. Holsboer has also directed many clinical studies and trials of new drugs for the treatment of depression, anxiety and insomnia. He has authored and co-authored over 600 scientific articles and has received numerous awards including the Gay Lussac/Alexander von Humboldt Price (1997), the Honorary Membership of the American Society of Psychiatrists (1998), the Membership of the Leopoldina (1998), the Gold Medal of the Japanese Society of Neurology and Psychiatry (1999), the Spinoza Chair of the University of Amsterdam (2001), the Marius-Tausk Visiting Professorship at the University of Leiden (2002) and the Anna Monica Price (2003).
Research Interest
clinical
